Clinical Trial Update: Inhaled NO in Prevention of Chronic Lung Disease [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating inhaled nitric oxide for preventing bronchopulmonary dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: University of California, San Francisco | Conditions: Bronchopulmonary Dysplasia, Lung Diseases | Phase 3 | Status: COMPLETED